Benno Weigmann Selected Research

Oxazolone

11/2022	Label-Free Characterization and Quantification of Mucosal Inflammation in Common Murine Colitis Models With Multiphoton Imaging.
1/2020	The JAK1/3 inhibitor tofacitinib suppresses T cell homing and activation in chronic intestinal inflammation.
7/2017	Chemically induced mouse models of acute and chronic intestinal inflammation.
1/2017	Rectal Delivery of a DNAzyme That Specifically Blocks the Transcription Factor GATA3 and Reduces Colitis in Mice.
1/2017	Activation of Epithelial Signal Transducer and Activator of Transcription 1 by Interleukin 28 Controls Mucosal Healing in Mice With Colitis and Is Increased in Mucosa of Patients With Inflammatory Bowel Disease.
1/2016	Oxazolone-Induced Colitis as a Model of Th2 Immune Responses in the Intestinal Mucosa.
7/2014	TH9 cells that express the transcription factor PU.1 drive T cell-mediated colitis via IL-9 receptor signaling in intestinal epithelial cells.
9/2009	IRF4 selectively controls cytokine gene expression in chronic intestinal inflammation.
9/2008	The transcription factor NFATc2 controls IL-6-dependent T cell activation in experimental colitis.
7/2008	The transcription factor IFN regulatory factor-4 controls experimental colitis in mice via T cell-derived IL-6.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Benno Weigmann Research Topics

Disease

25	Colitis 12/2022 - 09/2004
21	Inflammation (Inflammations) 10/2021 - 01/2007
11	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 11/2022 - 09/2004
8	Ulcerative Colitis 10/2021 - 01/2005
7	Crohn Disease (Crohn's Disease) 01/2019 - 09/2004
5	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 12/2019 - 07/2011
4	Neoplasms (Cancer) 12/2022 - 12/2010
4	Colonic Neoplasms (Colon Cancer) 01/2017 - 12/2010
2	Colorectal Neoplasms (Colorectal Cancer) 12/2022 - 09/2012
2	Pneumonia (Pneumonitis) 10/2021 - 01/2019
2	Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome) 10/2021 - 07/2015
2	Colitis-Associated Neoplasms 01/2017 - 12/2010
2	Autoimmune Diseases (Autoimmune Disease) 01/2016 - 12/2002
2	Hyperglycemia 02/2014 - 08/2012
1	Neointima 01/2022
1	Arteriosclerosis 01/2022
1	Seasonal Allergic Rhinitis (Hay Fever) 10/2021
1	Drug Hypersensitivity (Drug Allergy) 01/2021
1	Pruritus (Itching) 01/2021
1	Pain (Aches) 01/2021
1	Neoplasm Metastasis (Metastasis) 01/2020
1	Lung Neoplasms (Lung Cancer) 01/2020
1	Flushing 03/2019
1	Porcine Reproductive and Respiratory Syndrome (PRRS) 01/2019
1	Arthritis (Polyarthritis) 08/2017
1	Hypersensitivity (Allergy) 04/2012

Drug/Important Bio-Agent (IBA)

17	CytokinesIBA 10/2021 - 01/2005
11	OxazoloneIBA 11/2022 - 01/2007
10	Interleukin-6 (Interleukin 6)IBA 12/2022 - 07/2008
8	Interleukin-9 (Interleukin 9)IBA 12/2022 - 07/2014
7	InterleukinsIBA 08/2017 - 07/2009
6	AllergensIBA 10/2021 - 07/2006
6	Transcription Factors (Transcription Factor)IBA 01/2017 - 12/2002
5	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2007
4	Immunoglobulin E (IgE)IBA 10/2021 - 04/2012
4	Insulin (Novolin)FDA Link 07/2017 - 07/2011
4	HaptensIBA 07/2017 - 01/2007
3	Dextran SulfateIBA 11/2022 - 01/2017
3	Interleukin-17 (Interleukin 17)IBA 01/2020 - 06/2011
3	Indicators and Reagents (Reagents)IBA 07/2017 - 01/2007
3	Sulfonic AcidsIBA 07/2017 - 01/2007
3	Interleukin-4 (Interleukin 4)IBA 01/2017 - 09/2004
2	FlavonoidsIBA 01/2022 - 02/2018
2	Cyclosporine (Ciclosporin)FDA LinkGeneric 10/2021 - 02/2015
2	Pharmaceutical PreparationsIBA 01/2021 - 03/2019
2	LigandsIBA 01/2021 - 01/2017
2	Interleukin-5 (Interleukin 5)IBA 01/2020 - 01/2017
2	Interleukin-13IBA 01/2020 - 01/2017
2	AntigensIBA 07/2017 - 01/2007
2	Phenobarbital (Luminal)FDA Link 07/2017 - 01/2007
2	Interleukin-23 (Interleukin 23)IBA 01/2017 - 09/2008
2	Messenger RNA (mRNA)IBA 01/2017 - 09/2009
2	AcidsIBA 01/2017 - 01/2015
2	FibrinIBA 07/2015 - 04/2012
2	NFATC Transcription FactorsIBA 09/2012 - 09/2008
2	Interferon Regulatory FactorsIBA 06/2011 - 09/2009
2	sodium sulfate (sodium bisulfate)FDA LinkGeneric 07/2009 - 01/2007
2	Dextrans (Dextran)FDA Link 07/2009 - 01/2007
1	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 01/2022
1	Tec protein-tyrosine kinaseIBA 10/2021
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2021
1	Neutralizing AntibodiesIBA 01/2020
1	Conditioned Culture MediaIBA 01/2020
1	tofacitinibIBA 01/2020
1	AutoantibodiesIBA 12/2019
1	NucleotidesIBA 01/2019
1	Lysine (L-Lysine)FDA Link 01/2019
1	ZeinIBA 01/2019
1	Deubiquitinating EnzymesIBA 01/2019
1	NLR ProteinsIBA 01/2019
1	Omalizumab (Xolair)FDA Link 01/2019
1	Tumor Suppressor Proteins (Proteins, Tumor Suppressor)IBA 01/2019
1	Pattern Recognition ReceptorsIBA 01/2019
1	ApigeninIBA 02/2018
1	epigallocatechin gallate (epigallocatechin-3-gallate)IBA 02/2018
1	Peptides (Polypeptides)IBA 07/2017
1	STAT1 Transcription FactorIBA 01/2017
1	Type II Tumor Necrosis Factor ReceptorsIBA 01/2017
1	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 01/2017
1	Interleukin-12 (IL 12)IBA 01/2017
1	NADPH Oxidases (NAD(P)H oxidase)IBA 01/2017
1	Catalytic DNA (Deoxyribozyme)IBA 01/2017
1	InterferonsIBA 01/2017
1	Interleukin-23 Subunit p19IBA 01/2017
1	Toll-Like Receptor 9IBA 01/2017
1	Interferon Regulatory Factor-3 (Interferon Regulatory Factor 3)IBA 01/2017
1	Budesonide (Pulmicort)FDA LinkGeneric 05/2016
1	2,4,6-trinitro-benzenesulfonic acidIBA 01/2016
1	Interleukin-10 (Interleukin 10)IBA 01/2016
1	Glycoproteins (Glycoprotein)IBA 07/2015
1	Interleukin-9 Receptors (Interleukin 9 Receptor)IBA 07/2014
1	proto-oncogene protein Spi-1IBA 07/2014
1	IgE Receptors (Fc epsilon RI)IBA 04/2012
1	Histamine (Histamine Dihydrochloride)FDA Link 04/2012
1	Platelet Activating FactorIBA 04/2012

Therapy/Procedure

6	Therapeutics 12/2022 - 01/2007
3	Transplantation 01/2022 - 07/2008
2	Immunotherapy 01/2016 - 08/2012
1	Topical Administration 07/2017
1	Injections 01/2017